Epstein-Barr virus, also known as human herpesvirus 4 (HHV-4) is a virus belonging to the herpes virus family that infects humans. It causes infectious mononucleosis, also known as mono, which is a symptomatic disease affecting adolescents and young adults. The virus also associated with several types of cancer such as Burkitt's lymphoma, lymphomas in immunocompromised individuals. The global EBV market comprises of diagnostic tests, therapeutics to treat EBV associated conditions and cancers.
The diagnostic segment is comprised immunoassays to detect antibodies against EBV and PCR based assays to detect EBV nucleic acid. The therapeutics segment includes antiviral drugs and monoclonal antibodies for EBV associated cancers. The major need of the EBV market lies in diagnosis and treatment of cancers caused due to EBV infection.
The Epstein-Barr Virus (EBV) market is estimated to be valued at USD 1.4 Billion in 2024 and is expected to reach USD 2.1 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.53% from 2024 to 2031.
Key players operating in the Epstein-Barr Virus (EBV) market are F. Hoffmann-La Roche Ltd, Qiagen NV, Abbott Laboratories, bioMerieux SA. Second, key opportunities lies in developing enhanced diagnostics and novel therapeutics for EBV associated cancers. Third, market players are focusing on expanding their geographic presence to emerging markets in Asia Pacific and Latin America owing to rising incidences of EBV related cancers.
Market Drivers
One of the key drivers of the global Epstein-Barr Virus (EBV) Market is rising incidences of EBV associated cancers worldwide. As per statistics by WHO, in 2020 there were over 2 million new cases of EBV associated cancers globally. This rising cancer burden is anticipated to drive the demand for advanced diagnostic tests and targeted therapies for EBV positive cancers.
Market Restraints
High costs associated with research and development of novel drugs for EBV treatment is one of the major challenges in the market. Since EBV is not life threatening in itself, big pharmaceutical companies are hesitant in investing huge capital for products targeting rare EBV associated cancers. Stringent regulatory norms also delay market approval and commercialization of new products, acting as a restraint.
Segment Analysis
The Epstein-Barr Virus (EBV) market can be segmented based on application into diagnostic tests, antiviral drugs, and vaccines. The diagnostic tests segment is currently dominating the market as it holds the largest share. This is because diagnostic testing plays a crucial role in confirming EBV infection and diagnosing associated diseases. It helps in identifying active viral infection, presence of EBV antibodies, and assessing disease progression. Some of the commonly used diagnostic tests for EBV include enzyme immunoassays, immunofluorescence assays, polymerase chain reaction, and serology tests.
Global Analysis
The North America region dominates the global EBV market currently and is expected to maintain its lead over the forecast period. This is attributed to factors such as rising incidence of infectious mononucleosis, favorable reimbursement policies, availability of advanced diagnostic technologies, and presence of key market players in the region. The Asia Pacific region is anticipated to witness the fastest growth during the forecast period owing to growing awareness about EBV diagnosis and treatment, increasing healthcare expenditure, and improving healthcare infrastructure in emerging countries such as China and India.
Get this Report in Japanese Language: エプスタイン・バーウイルス（EBV）市場
Get this Report in Korean Language: 엡스타인-바 바이러스(EBV) 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Epstein - Barr virus (EBV) drug market is also known as human herpesvirus 4 infection disease the cause of infectious mononucleosis.
It is spread transmitted through most commonly through bodily fluids, especially saliva.
The people with EBV infection can experience fatigue, fever, inflamed throat and swollen liver.According to the statistics published in Australian Academy of Science, it is estimated up to 200,000 cancers related disorders are directly attributed to Epstein-Barr virus every year and up to 95% of adult population carry Epstein-Barr virus.
The market growth is increased by introduction of novel therapies and rise in government initiatives may increase the Epstein-Barr virus infection drug market.Epstein-Barr virus drug market is rise gradually to a steady CAGR in the forecast period of 2019-2026.
The advancement in serological testing and introduction of Nucleic Acid Amplification Testing (NAT) to identify Zika virus in order to avail the treatment faster is the key factor for market growth.This Epstein - Barr Virus Drug Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.
The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market.
Remember all those stressful moments when you thought that you would not be able to make it through; like your examinations, a project deadline at work, or continuous work stress without rest, etc.
This is basically a repeated cycle in which people often suffer with an illness or develop flare-ups of a chronic condition.
It has been observed that the tendency of panic attacks is usually more on weekends than on weekdays and people tend to get more hyper and lose control of their mental conditions.
Our body is very adaptive to situations and in situations when there is excess stress the body releases hormones like glucocorticoids (like cortisol), catecholamines (like norepinephrine) and adrenaline.
While this phenomenon is going on, hormone called glucocorticoids can fuel up latent viral infections such as herpes simplex 1 causing cold sores and Epstein-Barr virus that usually results in fatigue, fever, sore throat and swollen glands.
These symptoms usually start to show after a few days as explained by behavioural neuroscientist.
Encephalitis is a rare, life-threatening disease which causes inflammation in the brain by either virus infection or immune system mistakenly destroys the healthy brain cell instead of the infected cell.
Rarely, it can also be caused by a bacterial or fungal infection.
It mostly occurs in children or older people or those who have a weekend immune system.
The symptoms of it vary with the severity of the disease.
Infants or children with encephalitis:
Bulging fontanel on the infant’s skull
